Results indicate that 98 percent of subjects (486/495) reported experiencing one of seven subtypes of dream-enacting behavior at least "rarely" in the last year. The most prevalent behavior subtype was "fear," with 93 percent reporting that they had felt signs of fear in their body after awakening from a frightening dream.
Seventy-eight percent reported that they had awakened from an erotic dream to find that they were sexually aroused; 72 percent had awakened from a happy dream to find that they were actually smiling or laughing. Each of the other four behavior subtypes was reported by more than 50 percent of participants: They awakened from a dream to find that they were talking, crying, acting out an angry or defensive behavior such as punching or kicking, or acting out other movements such as waving or pointing. Women reported more speaking, crying, fear and smiling/laughing than men, and men reported more sexual arousal.
Lead author and co-investigator Tore Nielsen, PhD, professor of psychiatry at the Université de Montreal in Canada, was surprised by the high prevalence of dream-enacting behavior. Nielsen noted that more studies will need to be conducted to create a distinction between normal dream-enacting behavior and actions that are associated with REM sleep behavior disorder (RBD), which is characterized by abnormal behaviors emerging during rapid eye movement (REM) sleep that cause injury or sleep disruption.
"Normal episodes are usually extremely mild, for example, briefly jerking an arm or leg while waking up from a nightmare, once or twice a year," said Nielsen. "This is far different from RBD cases, which are typically very intense, and might involve repeatedly flailing an arm or a leg or smashing into something in the middle of a dream, not waking up easily from it, with occurrences several times a month."
A total of 1,140 first-year undergraduate students who were enrolled in introductory psychology courses voluntarily participated in the study. Approximately two-thirds were female. Participants completed several questionnaires concerning personality and dreaming.
To determine the type of questions that are best for eliciting reports of dream-enacting behavior, students were divided into three groups. Group one (mean age 19.9 years) was provided with general questions concerning dream-enacting behaviors, group two (mean age 20.1 years) received the same questions with examples, and group three (mean age 19.1 years) received questions describing specific behavior subtypes. The prevalence of dream-enacting behavior increased with increasing question specificity (35.9 percent in group one, 76.7 percent in group two and 98.2 percent in group three). According to the authors, these findings suggest that dream-enacting behaviors are common in the general population but are difficult for subjects to identify if detailed descriptions of the behaviors are not given.
The study distinguished the dream-enacting behavior of speaking out loud some of the words of a dream about talking from somniloquy (sleep talking), which was defined as speaking or making sounds during sleep without clear recall of an accompanying dream. Acting out the movements of a dream was distinguished from somnambulism (sleepwalking), which was defined as moving or walking during sleep without clear recall of a dream. Almost 61 percent of subjects in group three reported experiencing somniloquy at least "rarely" in the last year, and 40.9 percent reported somnambulism.
The authors speculate that there is a possibility of a personality trait involvement and a genetically determined predisposition for frequent dream-enacting behaviors. It remains unknown whether the dream-enacting behaviors of healthy subjects may predict future RBD symptoms.
Sleep is the official journal of the Associated Professional Sleep Societies, LLC (APSS), a joint venture of the American Academy of Sleep Medicine and the Sleep Research Society. The APSS publishes original findings in areas pertaining to sleep and circadian rhythms. Sleep, a peer-reviewed scientific and medical journal, publishes 12 regular issues and 1 issue comprised of the abstracts presented at the SLEEP Meeting of the APSS.
For a copy of the study, "Dream-Enacting Behaviors in a Normal Population," or to arrange an interview with the study's author, please contact Kelly Wagner, AASM public relations coordinator, at (708) 492-0930, ext. 9331, or firstname.lastname@example.org.
AASM is a professional membership organization dedicated to the advancement of sleep medicine and sleep-related research. As the national accrediting body for sleep disorders centers and laboratories for sleep related breathing disorders, the AASM promotes the highest standards of patient care. The organization serves its members and advances the field of sleep health care by setting the clinical standards for the field of sleep medicine, advocating for recognition, diagnosis and treatment of sleep disorders, educating professionals dedicated to providing optimal sleep health care and fostering the development and application of scientific knowledge.
Kelly Wagner | EurekAlert!
Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology
Pan-European study on “Smart Engineering”
30.03.2017 | IPH - Institut für Integrierte Produktion Hannover gGmbH
The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.
To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
30.03.2017 | Physics and Astronomy
30.03.2017 | Studies and Analyses
30.03.2017 | Life Sciences